Objective-To see whether cardiac morphological and functional abnormalities in uraemic patients are determined by high blood pressure or if they are an expression of a specific cardiomyopathy. Design-Cross sectional study. Setting-City general hospital in Italy. Haemodialysis for chronic renal failure still carries high mortality (10% per year). Cardiovascular events are the main cause of death (50-60% against 15% in control populations).' Accelerated coronary atherosclerosis, which has been claimed to be linked to lipid abnormalities, high blood pressure, diabetes, altered oxygen delivery at cellular level, and to an unknown uraemic factor, seems to be closely related to this excessive mortality.23
regional dyskinesias, and pericarditis were excluded. 19 control normotensive subjects (6 men and 13 women), matched for age. Main outcome measures-Echocardiographic measurements of left atrium, left ventricular end diastolic and end systolic volume, aortic root diameter, posterior wall and interventricular septum thickness, left ventricle mass index, and ejection fraction in controls and in patients according to whether they were normotensive (five men, eight women) or hypertensive (12 Haemodialysis for chronic renal failure still carries high mortality (10% per year). Cardiovascular events are the main cause of death (50-60% against 15% in control populations).' Accelerated coronary atherosclerosis, which has been claimed to be linked to lipid abnormalities, high blood pressure, diabetes, altered oxygen delivery at cellular level, and to an unknown uraemic factor, seems to be closely related to this excessive mortality. 23 The natural course of disease in these patients is also characterised by congestive heart failure, possibly as a result of a specific uraemic cardiomyopathy. (DecTE, DecTA) ; the ratio of velocities in A and E waves (A/E); area of waves E and A (SE, SA); SA/SE + SA; and isovolumic relaxation time.'720 Echo measurements were performed by a cardiologist and data analysed by two well trained observers; intrasample and intersample variability were low (coefficient of variation 3%). Each measurement was done twice, and the average of the results obtained over three consecutive cardiac cycles was used.
Blood pressure was measured before and after each haemodialysis, but patients were allocated to the hypertensive or normotensive group by using the data from the 48 hours of continuous ambulatory monitoring, which was carried out in the short time between dialysis. Ambulatory monitoring data were also used because they correlate more strongly than blood pressure measured in a surgery with the prevalence of cardiovascular complications such as cardiac hypertrophy."2 13 A Spacelabs 90207 instrument was used for this purpose. Patients with a mean hourly blood pressure that was always lower than 160 or 95 mm Hg, or both, were considered to be normotensive. Patients with a mean hourly blood pressure greater than or equal to 160 or 95 mmHg, or both, were considered to be hypertensive. Patients whether differences in cardiac mass were related to sex. 43 (4) 43 (5) 43 ( (six), and adult polycystic kidney disease (three) (X2 = 3-61, NS). Table 2 shows the ambulatory blood pressures over 48 hours in the three groups. Control subjects had similar blood pressures to normotensive uraemic patients, but significantly lower blood pressures than the hypertensive uraemic patients (P < 0-001 for all the variables analysed). Systolic and diastolic blood pressures were always significantly higher in the hypertensive patients than in the normotensive patients.
Multiple logistic regression analysis with hypertension as the dependent variable was not related to sex, blood urea nitrogen, creatinine concentration, phosphataemia, serum albumin concentration, parathyroid hormone concentration, serum concentrations of calcium, sodium, and potassium, packed cell volume, or KT/V as predictors. Parathyroid hormone concentration was 229-9 (276-0) nmol/l in the normotensive uraemic patients and 247-9 (207-4) nmol/l in the hypertensive uraemic patients (normal range 5-50 nmol/1). Table 3 summarises the echocardiographic measurements in the three groups. Interventricular septal and posterior wall thicknesses, systolic left atrial diameter, and aortic root diameter were significantly higher in the uraemic patients (P < 0-0001). Left ventricular end diastolic diameter and cardiac mass were also significantly different (P < 0-001 and P = 0-017 respectively).
No significant differences were found in ejection fraction. When the two subgroups of hypertensives and normotensives were compared, only the interventricular septal and posterior wall thicknesses and cardiac mass were significantly higher in the first group. There was no overlap between uraemic and control patients in interventricular septal and posterior wall thicknesses. Overlap was almost completely absent between hypertensive and normotensive patients undergoing dialysis. No correlation was found between the length of time receiving dialysis and any of the echocardiographic parameters analysed.
There was a significantly positive correla-Left ventnicular morphology and diastolic function in uraemia: echocardiographic evidence of specific cardiomyopathy 8 8) 99-3 ( 7 7) 3-44 0 04
One way analysis of variance was used.
VmaxE, E wave maximal velocity; AccE, E wave acceleration; DecE, E wave deceleration; AccTE, E wave acceleration time; DecTE, E wave deceleration time; SE, E wave area; VmaxA, A wave maximal velocity; AccA, A wave acceleration; DecA, A wave deceleration; AccTA, A wave acceleration time; DecTA, A wave deceleration time; SA, A wave area; ISA, SA/SA + SE; A/E, A wave area/E wave area; IVRT, isovolumic relaxation time.
*Significantly different v patients with uraemia.
tion between left ventricular mass index and mean diastolic blood pressure over 48 hours (P < 0 05), average nocturnal diastolic blood pressure (P < 0 05), and average nocturnal systolic blood pressure (P < 0 05), which are considered to be indices of cardiac workload. There was no correlation between the 48 hour ambulatory blood pressure parameters and the following indices of diastolic function: SA, SE, SA/SE, and isovolumic relaxation time. Similarly, no correlation was found between left ventricular mass index and interventricular septal and posterior wall thicknesses and SA, SE, SA/SE, and isovolumic relaxation time. Parathyroid hormone concentrations also did not correlate with these indices of diastolic function.
Discussion
Chronic renal failure is accompanied by a high prevalence of morphological and functional changes in the heart, and these can easily be detected by echocardiography. These abnormalities are responsible for the high incidence of congestive heart failure and cardiac mortality in affected patients.2 Many authors ascribed these changes to coronary heart disease or hypertension, which are both often found in uraemic patients receiving dialysis. These patients might develop a specific cardiomyopathy, secondary to their specific metabolic, biochemical, hormonal, and maybe even haemodynamic features (atrioventricular fistula).4 2 In the early phases of uraemic cardiomyopathy the interventricular septum and the posterior wall become thickened in association with appreciable dilatation of the left atrium in 40% of patients. Global dilatation of the left ventricle occurs only in the late stages,23 and some authors consider this to be the result of high blood pressure, which is often found in these subjects,'4 rather than of intrinsic changes due to uraemia.
Our blood pressure data are from 48 hour monitoring; in other studies such data seem to be closely correlated to the prevalence of complications, the degree of cardiac hypertrophy, and the alterations in diastolic function.1'-14 A cut off point between hypertension and normotension in uraemic patients of 160/90 mm Hg might seem arbitrary, but this was an attempt to include isolated systolic hypertension (defined in large clinical trials such as SHEP'5 and SYST-EUR greater than 160 mm Hg) and systodiastolic hypertension. A similar cut off point was adopted in a previous study using ambulatory blood pressure monitoring in patients undergoing haemodialysis.9 Our morphological data are similar to published data; in fact, uraemic patients have much thicker ventricle walls, a greater left ventricular mass, and a higher degree of dilatation. Within these patients, hypertensive subjects show a significantly higher left ventricular mass and thicker interventricular septum. However, the presence of morphological changes even in the subgroup of normotensive uraemic patients indicates that chronic renal failure or its inadequate correction by haemodialysis may have an important and independent role. Hypertension can worsen the degree of hypertrophy. Left 46 Myocardial stiffness in uraemic patients seems to be complex, with many factors contributing to the development of cardiac hypertrophy. This is not the case for left ventricular mass, which correlates well with blood pressure monitored over 48 hours and therefore with cardiac workload.
We think that the increased myocardial stiffness is determined also by uraemia. In fact, we recently showed that contractility of single isolated myocytes, as well as their intrinsic speed of shortening and relaxation, is depressed in rats with chronic uraemia. These changes were not ascribed to myocyte hypertrophy since contractile proteins did not show the typical shift towards the slow myosin isoforms of the hypertrophied myocardium. We hypothesised that cardiotoxic substances produced during uraemia could slow down contraction and relaxation. 40 Hyperparathyroidism may have an important role in the pathogenesis of uraemic cardiomyopathy.6 7 Indeed, our patients have high concentrations of parathyroid hormone regardless of their blood pressure. We found no correlations between parathyroid hormone concentration and indices of diastolic function, but we cannot say that abnormal diastolic function is not affected by parathyroid hormone. The same may be true for other variables such as haemoglobin, ions, and other metabolites, whose concentrations were almost identical in the two groups of uraemic patients. Recently, however, "uraemic cardiodepressant factors" with molecular weights between 10 000 and 30 000 daltons have been identified.8 Therefore specific substances may modify the composition of the interstitium, as well as metabolic factors, ions, and hormones. Further studies are needed to identify a cause and effect relation.
